Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by CENTRAL TRUST Co

CENTRAL TRUST Co grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,512 shares of the medical equipment provider’s stock after purchasing an additional 269 shares during the period. CENTRAL TRUST Co’s holdings in Intuitive Surgical were worth $1,311,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in ISRG. Czech National Bank lifted its stake in Intuitive Surgical by 6.9% during the third quarter. Czech National Bank now owns 72,257 shares of the medical equipment provider’s stock worth $35,498,000 after purchasing an additional 4,665 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Intuitive Surgical by 31.2% during the third quarter. GAMMA Investing LLC now owns 5,090 shares of the medical equipment provider’s stock worth $2,501,000 after acquiring an additional 1,211 shares during the period. Consilio Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the third quarter worth $218,000. Miracle Mile Advisors LLC increased its position in shares of Intuitive Surgical by 7.7% during the third quarter. Miracle Mile Advisors LLC now owns 1,805 shares of the medical equipment provider’s stock worth $887,000 after acquiring an additional 129 shares during the period. Finally, Fulton Bank N.A. increased its position in shares of Intuitive Surgical by 7.4% during the third quarter. Fulton Bank N.A. now owns 3,070 shares of the medical equipment provider’s stock worth $1,508,000 after acquiring an additional 211 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This trade represents a 72.34 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $578.55 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $550.40 and a 200-day simple moving average of $510.02. The company has a market capitalization of $206.07 billion, a price-to-earnings ratio of 90.26, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.